WASHINGTON (Reuters) - The U.S. Food and Drug Administration on Friday approved Shire Plc's stimulant Vyvanse to treat binge-eating disorder, the first product to be approved for the condition.
On the face of it, ADHD medications look complicated – there are a lot of them. Not only patients, but many providers have a hard time making sense of them, especially as there are new ones on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results